Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.

Clinical trial NCT06500247 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06500247
Sponsor: Qilu Hospital of Shandong University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

The Efficacy of Abiraterone Acetate Combined With Dalpicilib in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

Start date: 2024-07-31
Primary completion: 2027-03-31
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.